21171 ⎘
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA; Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
IMMUNOGENIC COMPOSITIONS FOR GRAM POSITIVE BACTERIA
#602DNA vaccines against tumor growth and methods of use thereof
#603LIVE BACTERIAL VACCINES RESISTANT TO CARBON DIOXIDE (CO2), ACIDIC PH AND/OR OSMOLARITY FOR VIRAL INFECTION PROPHYLAXIS OR TREATMENT
#604Live bacterial vaccines resistant to carbon dioxide (CO2), acidic PH and/or osmolarity for viral infection prophylaxis or treatment
#605HOLIN-ENHANCED VACCINES AND REAGENTS, AND METHODS OF USE THEREOF
#606hyperexpressing recombinant cholera toxin B subunit showing dual immunogenicity
#607Regulated expression of antigen and/or regulated attentuation to enhance vaccine immunogenicity and/or safety
#608Compositions and methods for targeted ablation of mutational escape of targeted therapies for cancer
#609Compositions and methods to elicit immune responses against pathogenic organisms using yeast based vaccines
#610TREATMENT OF IMMUNE DISEASE BY MUCOSAL DELIVERY OF ANTIGENTS USING GENETICALLY MODIFIED LACTOBACILLUS
#611Recombinant intracellular pathogen immunogenic compositions and methods of use
#612INFLUENZA VACCINE
#613Carrier
#614Enhancing of hepatitis B virus vaccine and its gene
#615Procedure For Expressing A Tbpb Protein On The Bacterial Surface Of An Attenuated Oral Live Vaccine As Prototype Of A Meningitis B Vaccine
#616Recombinant BCG strains with enhanced ability to escape the endosome
#617COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE TO ESCAPE MUTANTS OF TARGETED THERAPIES
#618Exoenzyme toxin of , and uses therefor
#619Live attenuated aldolase-negative bacterial vaccine
#620Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon response
#621Methods for stimulating an immune response using bacterial antigen delivery system
#622LIVE BACTERIAL VACCINE
#623Oral vaccines
#624Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
#625Recombinant double stranded RNA nucleocapsid and use of the same
#626NOVEL PRIME-BOOST COMBINATIONS OF ATTENUATED MYCOBACTERIUM
#627Yeast-antigen compositions and methods of using the same
#628Soluble Fragments of The Sars-Cov Spike Glycoprotein
#629RECOMBINANT MYCOBACTERIUM STRAIN EXPRESSING A MYCOBACTERIAL FAP PROTEIN UNDER THE CONTROL OF A PROMOTER ACTIVE UNDER HYPOXIA AND ITS APPLICATION FOR CANCER THERAPY
#630Oral vaccine for
#631based oral vaccines for anthrax
#632FLAGELLIN POLYPEPTIDE VACCINES
#633Recombinant newcastle disease virus RNA expression systems and vaccines
#634Live attenuated bacterial vaccine
#635MEANS AND METHODS FOR MANIPULATING SEQUENTIAL PHAGOLYSOMALCYTOSOLIC TRANSLOCATION OF MYCOBACTERIA, AND USES THEREOF
#636BACILLE CALMETTE-GUERIN (BCG)-BASED ANTI-ATHEROMA VACCINE AND METHODS OF USE THEREOF
#637Live attenuated strains as a single dose vaccine against whooping cough
#638Type III secretion pathway in and uses therefor
#639system and uses thereof
#640METHOD FOR PRODUCING EPITOMERS AND THEIR USES ON CARRIER MICROORGANISMS
#641Combination vaccines with whole cell pertussis antigen
#642Compositions comprising HMW-MAA and fragments thereof, and methods of use thereof
#643Immunogenic compositions for activating γδ T cells
#644Compositions comprising HMW-MAA and fragments thereof, and methods of use thereof
#645mutant with enhanced homologous recombination and uses thereof
#646Immunostimulatory recombinant intracellular pathogen immunogenic compositions and methods of use
#647RECOMBINANT LACTOBACILLUS AND USE OF THE SAME
#648Mesothelin vaccines and model systems
#649Antigens and vaccines against
#650Modified vaccinia virus strains for use in diagnostic and therapeutic methods
#651Microbial vaccine and vaccine vector
#652Induction of mucosal tolerance to antigens
#653Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
#654Therapeutic composition for use in the prevention and treatment of bone metastases
#655Yeast-based vaccines as immunotherapy
#656Yeast-based vaccines as immunotherapy
#657Adhesin-enterotoxin chimera based immunongenic composition against enterotoxigenic
#658Immunizing compositions comprising nucleic acids encoding the HIV-1 matrix protein myristate binding site
#659Composition Comprising a Colloidal Synthetic Bioresorbable Vector and a Viral Vector
#660Method for preventing or treating infection
#661Multivalent vaccines comprising recombinant viral vectors
#662Vector for anti-HPV vaccine and transformed microorganism by the vector
#663Immunogenic and therapeutic compositions for
#664Mesothelin Vaccines and Model Systems and Control of Tumors
#665Methods for attenuating virus strains for diagnostic and therapeutic uses
#666Method of making immunogenic compositions comprising UV-irradiated, psoralen-inactivated, desialated human immunodeficiency virus (HIV) particles devoid of CD55 and CD59 in the viral membrane
#667Method of inducing an immune response in a host by administering immunogenic compositions comprising UV-irradiated, psoralen-inactivated, desialated human immunodeficiency virus (HIV) particles devoid of CD55 and CD59 in the viral membrane
#668Yeast-based vaccines as immunotherapy
#669Transgenic algae for delivering antigens to an animal
#670KENNEL COUGH VACCINE
#671Compositions and methods for treatment of cervical cancer
#672Colonization factor (CF) antigens of enterotoxigenic escherichia coli in recombinant bacteria
#673Type III secretion pathway in , and uses therefor
#674KENNEL COUGH VACCINE
#675Yeast-based therapeutic for chronic hepatitis C infection
#676Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon response
#677Recombinant negative strand RNA virus expression systems and vaccines
#678Recombinant BCG vaccine
#679protein, nucleic acid sequence and uses thereof
#680Modified vaccinia virus strains for use in diagnostic and therapeutic methods
#681fHbp- AND LPXL1-BASED VESICLE VACCINES FOR BROAD SPECTRUM PROTECTION AGAINST DISEASES CAUSED BY NEISSERIA MENINGITIDIS
#682Immunizing compositions comprising recombinant attenuated self-replicating viral RNA replicons encoding an epitope obtained from the HIV-1 matrix protein myrstate binding site
#683Bacterial delivery of biologically active polypeptides
#684-derived vaccine and therapy against botulism
#685Human papillomavirus vaccine for oral administration
#686Novel Brachyspira hyodysenteriae vaccine
#687Methods and compositions for combinatorial-based production of multivalent recombinant antigens
#688Genetically modified parasites expressing protective tick antigens and uses thereof
#689Product Comprising a C4bp Core Protein and a monomeric Antigen, and Its Use
#690Electroporation of and overexpression of antigens in mycobacteria
#691Attenuated mycobacteria as vectors for gene delivery to mammalian cells
#692USE OF AN AVIRULENT BORDETELLA MUTANT AS A LIVE VACCINE VECTOR
#693Mycobacteria expressing HIV-1 and malaria antigens
#694Virulence genes, proteins, and their use
#695Methods and compositions for treating IgE-mediated diseases
#696Attenuated serovar paratyphi a and uses thereof
#697Novel Efficient Production Process for Capsular Polysaccharides of Pathogenic Grampositive Bacteria by Heterologous Expression and Secretion of Complex Polysaccharides in Non-Pathogenic, Non-Invasive Gram-Positive Bacteria
#698Live, oral vaccine for protection against serotype 1
#699Proteins and nucleic acids from meningitis/sepsis-associated
#700Apoptosis-inducing polypeptides
#701Identification of genes
#702Listeriolysin-Containing Bacillus Spores as Antigen Delivery Agents
#703METHODS AND COMPOSITIONS FOR INCREASED PRIMING OF T-CELLS THROUGH CROSS-PRESENTATION OF EXOGENOUS ANTIGENS
#704Apoptosis-inducing polypeptides
#705Antibiotic resistance free vaccines and methods for constructing and using same
#706Campylobacter Jejuni Outer Membrane Protein Immunogenic Composition
#707Gut commensal bacterium and methods of using the same
#708LIVE BACTERIAL VACCINES FOR VIRAL INFECTION PROPHYLAXIS OR TREATMENT
#709Methods for administering tumor vaccines
#710Bacterial Packaging Strains Useful for Generation and Production of Recombinant Double-Stranded RNA Nucleocapsids and Uses Thereof
#711Yeast-based therapeutic for chronic hepatitis C infection
#712Recombinant BCG strains with enhanced ability to escape the endosome
#713Attenuated salmonella SP12 mutants as antigen carriers
#714Salmonella vaccine
#715Yeast-based vaccines as immunotherapy
#716Yeast-based therapeutic for chronic hepatitis C infection
#717vaccine
#718Transformed bacteria producing CS6 antigens as vaccines
#719Yeast-based vaccine for inducing an immune response
#720Vaccine Compositions Which Are Obtained From Streptomyces
#721Recombinant attenuated organisms and vaccine
#722Live Attenuated Bacterial Vaccine
#723Kennel cough vaccine
#724Exoenzyme toxin of , and uses therefor
#725Method of Regulating Heterologous Protein Expression Controlled by Salicylic Deratives in Micro-Organisms Associated with Higher Organisms
#726Compositions and methods comprising a MAGE-b antigen
#727Compositions and methods comprising KLK3 of FOLH1 antigen
#728Gene Construction, Vector and Dna Vaccine for the Vaccination of Aquatic Animals
#729Construction of live attenuated vaccine strains that express CFA/I antigens (CfaB and CfaE) and the B subunit of heat-labile enterotoxin (LTB) from enterotoxigenic
#730Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells
#731Ras mutation and compositions and methods related thereto
#732Protein NMB1125 and use thereof in pharmaceutical formulations
#733Engineered listeria and methods of use thereof
#734Engineered and methods of use thereof
#735Compositions and Methods to Elicit Immune Responses Against Pathogenic Organisms Using Yeast Based Vaccines
#736Yeast-antigen compositions methods of making the same
#737EDIBLE VACCINE
#738Recombinant protective protein from
#739system and uses thereof
#740Inactivated host cell delivery of polynucleotides encoding immunogens
#741Recombinant protective protein from
#742Protein nmb0928 and use thereof in pharmaceutical formulations
#743Recombinant intracellular pathogen immunogenic compositions and methods for use
#744DNA vaccines against tumor growth and methods of use therof
#745Multimeric complexes of antigens and adjuvants
#746Compositions and methods for treating tumors presenting survivin antigens
#747Orally-administered live bacterial vaccines for plague
#748Compositions and methods for inhibiting white spot syndrome virus (wssv) infection
#749Mucosal immunization to prevent prion infection
#750Escherichia coli-derived vaccine and therapy against botulism
#751Methods of eliciting or boosting a cellular immune response
#752Recombinant Vibrio cholerae strain and vaccine comprising said strain
#753Method for introducing and expressing genes in animal cells, and live invasive bacterial vectors for use in the same
#754Genetically modified tumor-targeted bacteria with reduced virulence
#755Recombinant double-stranded RNA phage, and use of the same
#756Soluble fragments of the SARS-CoV spike glycoprotein
#757Cells used as carriers for bacteria
#758Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector
#759Recombinant adenoviral vectors and applications thereof
#760Oral DNA composition for hepatitis B virus chronic infection
#761Detoxified TNF and method of preparing
#762Identification of genes
#763Recombinant BCG vaccine
#764Compositions and methods for enhancing the immunogenicity of antigens
#765Proteins in enteroaggregative (EAEC) useful for diagnosis and therapy of EAEC infections
#766Proteins in enteroaggregative (EAEC) useful for diagnosis and therapy of EAEC infections
#767Polynucleotides encoding novel proteins in enteroaggregative (EAEC) useful for diagnosis and therapy of EAEC infections
#768Polynucleotides encoding novel proteins in enteroaggregative (EAEC) useful for diagnosis and therapy of EAEC infections
#769Antibodies to novel proteins in enteroaggregative (EAEC) useful for diagnosis and therapy of EAEC infections
#770Antibodies to novel proteins in enteroaggregative (EAEC) useful for diagnosis and therapy of EAEC infections
#771Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
#772Adhesin as immunogen against enterotoxigenic
#773Novel brachyspira hyodyseteriae vaccine
#774Process for the preparation of an improved strain plasmid to develop the strain and the vaccine comprising the said strain
#775Recombinant double-stranded RNA phages and uses thereof
#776Cell surface expression vector of sars virus antigen and microorganisms transformed thereby
#777Transformed bacterium lacking selectable marker and overexpression of antigens in mycobacteria
#778High cell density process for growth of Listeria
#779Protein and peptide expression for passive immunity
#780Recombinant BCG strains with attenuated immunosuppressive properties
#781Yeast-based therapeutic for chronic hepatitis C infection
#782Non-human herpesviruses as vectors
#783Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors
#784Methods for constructing antibiotic resistance free vaccines
#785Yeast-dendritic cell vaccines and uses thereof
#786-based and LLO-based vaccines
#787Composition for delivering an agent to a target cell and uses thereof
#788Helicobacter system and uses thereof
#789Plasmid maintenance system for antigen delivery
#790Plasmid maintenance system for antigen delivery
#791Plasmid maintenance system for antigen delivery
#792Suicidal mutant vaccine
#793Recombinant spores
#794DNA vaccines encoding CEA and a CD40 ligand and methods of use thereof
#795Method of making microalgal-based animal foodstuff supplements, microalgal-supplemented animal foodstuffs and method of animal nutrition
#796Listeria-based EphA2 vaccines
#797Novel targets and compositions for use in decontamination, immunoprophylaxis, and post-exposure therapy against anthrax
#798Intranasal recombinant Salmonella vaccine encoding heterologous polysaccharide antigens
#799Salmonella vaccine materials and methods
#800Genetically modified tumor-targeted bacteria with reduced virulence
#801Vector for anti-HPV vaccine and transformed microorganism by the vector
#802Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof
#803Bacterial spores
#804Vaccine against microbial pathogens
#805Virulence genes, proteins, and their use
#806Methods for the prevention of malaria
#807Identification of virulence associated regions RD1 and RD5 leading to improve vaccine of BCG and
#808Nucleotide sequence coding for a tolc and a defined amino acid sequence
#809Immunogenic composition and method of developing a vaccine based on fusion protein
#810Immunizing compositions encoding an epitope obtained from the HIV-1 capsid protein cyclophilin A binding site
#811Methods for the prevention of malaria
#812DNA immunocontraceptive vaccines and uses thereof
#813Mesothelin vaccines and model systems
#814Neisserial vaccine compositions and methods
#815Method for the identification of tissue-specific regulatory sequences
#816Brachyspira hyodysenteriae vaccine
#817Exoenzyme toxin of , and uses thereof
#818Use of bacterial 5' untranslated regions for nucleic acid expression
#819LAWSONIA INTRACELLULARIS PROTEINS, AND RELATED METHODS AND MATERIALS
#820Immunogenic compositions including rough phenotype host strains and complementation DNA fragments
#821Compositions and methods for bacterial immunity and secretion of proteins
#822Isolation and characterization of the operon (ETEC-CS4 pili) and methods of using same
#823Radio lan access authentication system
#824Bacterial vectors and methods of use thereof
#825Immunogenic compositions comprising UV-irradiated, psoralen-inactivated, desialated human immunodeficiency virus (HIV) devoid of CD55 and CD59 in the viral membrane
#826Immunogenic compositions capable of eliciting Th1 immune responses comprising an HIV-1 MA myristate binding site polypeptide
#827Immunogenic composition and method of developing a vaccine based on factor H binding sites
#828Neisseria mutants, lipooligosaccharides and immunogenic compositions
#829Regulated antigen delivery system (RADS)
#830Campylobacter jejuni outer membrane protein immunogenic composition
#831Recombinant process for preparing a complete malaria antigen gp190/MSP1
#832Methods and composition for delivering nucleic acids and/or proteins to the intestinal mucosa
#833Methods and reagents for decreasing clinical reaction to allergy
#834Immunogenic CEA
#835Type III secretion pathway in , and uses therefor
#836Apoptosis-inducing polypeptides
#837Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
#838Transformed bacteria producing CS6 antigens as vaccines
#839Vaccine
#840Composition for delivering an agent to a target cell and uses thereof
#841Plasmid maintenance system for antigen delivery
#842SARS-coronavirus virus-like particles and methods of use
#843Immunization and/or treatment of parasites and infectious agents by live bacteria
#844Immunization and/or treatment of parasites and infectious agents by live bacteria
#845DNA vaccines against tumor growth and methods of use thereof
#846Vaccination against host cell-associated herpes viruses